Active	Status	Sponsor type	Region	Phase	Filter
7 Active 5 Inactive 12 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

7 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Vries, Elisabeth GE de
NCT02478099 / 2015-000907-19: MPDL3280A-treatment-IST-UMCG	Active, not recruiting	2	81	Europe	MPDL3280A	University Medical Center Groningen	Locally Advanced or Metastatic Solid Tumors	09/23	07/24
NCT06534190: CD8 PET Imaging in Metastatic Solid Tumours	Not yet recruiting	2	30	Europe	89Zr-Df-crefmirlimab PET scan, Nivolumab, Cetrelimab, zirconium Zr 89 crefmirlimab berdoxam, Zr-89 crefmirlimab berdoxam, 89Zr-Df-crefmirlimab, 89Zr-Df-IAB22M2C	University Medical Center Groningen	Locally Advanced Solid Tumor	11/28	11/28
CBT307-1, NCT05836623: A Phase I Study to Assess PSMA+ and PSMA- Tumour Lesions	Active, not recruiting	1	5	Europe	Radiolabelled CB307, 89Zr-CB307, CB307	Crescendo Biologics Ltd., University Medical Center Groningen	Advanced and/or Metastatic Solid Tumours	01/24	10/24
POTENTIA, NCT04839991: Study of CB307 in Patients With Advanced and/or Metastatic PSMA-positive Tumours.	Recruiting	1	70	Europe, US	CB307	Crescendo Biologics Ltd.	Advanced and/or Metastatic Solid Tumours	07/24	09/24
NCT02453984: MPDL3280A-imaging-IST-UMCG	Active, not recruiting	N/A	45	Europe	89Zr-MPDL-3280A-PET scans	University Medical Center Groningen	Locally Advanced or Metastatic Solid Tumors Irrespective of PD-L1 Expression	11/20	06/24
NCT03850028 / 2017-003511-20: Molecular Imaging Using Radiolabeled Atezolizumab to Assess Atezolizumab Biodistribution in Lymphoma Patients	Withdrawn	N/A	20	Europe	89Zr-atezolizumab PET scans	University Medical Center Groningen, Amsterdam UMC, location VUmc, Stichting Hemato-Oncologie voor Volwassenen Nederland, Hoffmann-La Roche	Diffuse Large B-Cell Lymphoma, Not Otherwise Specified	05/22	05/22
Tilson, Julia
CBT307-1, NCT05836623: A Phase I Study to Assess PSMA+ and PSMA- Tumour Lesions	Active, not recruiting	1	5	Europe	Radiolabelled CB307, 89Zr-CB307, CB307	Crescendo Biologics Ltd., University Medical Center Groningen	Advanced and/or Metastatic Solid Tumours	01/24	10/24